Population pharmacokinetics and enterohepatic recirculation of hyzetimibe and its main metabolite in Chinese healthy subjects

Pharmacokinetic Study of Oral 14C-Radiolabeled Hyzetimibe, A New Cholesterol Absorption Inhibitor

(2021) Jianwei Liao et al.   Frontiers in Pharmacology

Delay differential equations for the description of Irbesartan pharmacokinetics: A population approach to model absorption complexities leading to dual peaks

(2020) Eleni Karatza et al.   EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES

Population pharmacokinetic model of irinotecan and its metabolites in patients with metastatic colorectal cancer

(2019) Esther Oyaga-Iriarte et al.   EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY

Mycophenolic Acid and Its Metabolites in Kidney Transplant Recipients: A Semimechanistic Enterohepatic Circulation Model to Improve Estimating Exposure

(2018) Malek Okour et al.   JOURNAL OF CLINICAL PHARMACOLOGY

On the population pharmacokinetics and the enterohepatic recirculation of total ezetimibe

(2018) Konstantina Soulele et al.   XENOBIOTICA

Development of a joint population pharmacokinetic model of ezetimibe and its conjugated metabolite

(2018) K. Soulele et al.   EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES

Population pharmacokinetics of mycophenolic acid and its glucuronide metabolite in lung transplant recipients with and without cystic fibrosis

(2016) Xiao-Xing Wang et al.   XENOBIOTICA

Population pharmacokinetics of fluticasone propionate/salmeterol using two different dry powder inhalers

(2015) K. Soulele et al.   EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES

Population pharmacokinetics of mycophenolic acid and its main glucuronide metabolite: a comparison between healthy Chinese and Caucasian subjects receiving mycophenolate mofetil

(2014) Jing Ling et al.   EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY

Pharmacokinetics, pharmacodynamics, safety, and tolerability of hyzetimibe (HS-25) in healthy Chinese subjects

(2014) Zhourong Ruan et al.   JOURNAL OF CLINICAL PHARMACOLOGY

Population pharmacokinetic model to analyze nevirapine multiple-peaks profile after a single oral dose

(2014) Manuel Ibarra et al.   JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS

Population Pharmacokinetic Model for Cancer Chemoprevention With Sulindac in Healthy Subjects

(2013) Alexander K. Berg et al.   JOURNAL OF CLINICAL PHARMACOLOGY

Enterohepatic recirculation model of irinotecan (CPT-11) and metabolite pharmacokinetics in patients with glioma

(2008) Islam R. Younis et al.   CANCER CHEMOTHERAPY AND PHARMACOLOGY